Morally Produced Shingles Vaccine Approved in Both US and Canada

Children of God for Life recently announced that the long-awaited, morally produced shingles vaccine has received FDA approval for licensing in the US. Shingrix, made by Glaxo SmithKline (GSK) pharmaceutical company is produced using a yeast cell line, unlike Merck’s Zostavax which uses aborted fetal cells. “Until now, people wanting to have protection from shingles have had to either use Merck’s aborted fetal version or abstain entirely,” stated Debi Vinnedge, Executive Director at Children of God for Life. “We are absolutely thrilled that GSK has finally given the US a moral option!”

“I commend GSK for the development of Shingrix,” said John F Brehany, Director of Institutional Relations at the National Catholic Bioethics Center. “And I commend the thousands of people who by their prayers and petitions have helped to bring about this day. I hope they will redouble their efforts. Safe, effective, and ethical vaccines can and should be provided by the pharmaceutical companies. And everyone who respects human life and dignity should make use of these ethical alternatives.”

Likewise, the US Conference of Bishops noted in their April 2015 updated statement that, “The Secretariat of Pro-Life Activities agrees with the National Catholics Bioethics Center, the Catholic Medical Association, and others that manufacturers should be urged to make alternative vaccines more widely available so that Catholics and others will not face this moral dilemma.